Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1512 participants.

Also called NCT04974333

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,512 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04974333
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04974333. Randomized; no masking; primary purpose treatment. Start 2021-10-04 (actual); primary completion 2023-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes
Acronym
SANENT
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
Mobile health application on phone
Lead sponsor
General Health Council, Mexico (class: other government)
Collaborator
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (class: other government)
Collaborator
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct04974333
Content hash
bc3de567608775d7eabeed88b6147d6a423bc01f81d7b79c0fe6a29069c33129